Shang Kai, Zhu Wangshu, Ye Lifang, Li Yuehua
Institute of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 600 Yishan Road, Xuhui District, Shanghai, 200235, China.
Neuroradiology. 2023 Nov;65(11):1657-1663. doi: 10.1007/s00234-023-03210-0. Epub 2023 Aug 29.
This study aimed to investigate the long-term functional outcome of patients with different degrees of thrombus perviousness (TP) undergoing mechanical thrombectomy alone and those undergoing combined intravenous thrombolysis (IVT) plus mechanical thrombectomy.
We conducted a retrospective analysis of consecutive patients with acute ischemic stroke due to large vessel occlusion who underwent mechanical thrombectomy alone or bridging therapy between January 2016 and October 2020. TP was quantified by thrombus attenuation increase (TAI) on admission computed tomography angiography compared with non-contrast computed tomography. After dichotomization of TAI as higher or lower perviousness, Fisher exact tests were performed to estimate the associations of different therapies with favorable functional outcomes [Modified Ranking Scale score at 90 days (90-day mRS) of 0 to 2].
A total of 73 patients were included in our study. 35 (47.9%) thrombi were classified as higher-perviousness clots with TAI of ≥ 24 HU, and the other 38 thrombi were lower-perviousness clots. A favorable outcome with a 90-day mRS of 0 to 2 was observed in 32 patients. In patients with thrombi of lower perviousness, favorable outcome was more common in the bridging therapy group than in the thrombectomy-alone group (p = 0.013), whereas in patients with thrombi of higher perviousness, the long-term neurological outcome did not significantly differ between two therapy groups (p = 0.094).
Patients with thrombi of lower perviousness were recommended to undergo intravenous alteplase followed by endovascular thrombectomy, and those with thrombi of higher perviousness could undergo thrombectomy alone.
本研究旨在调查单纯接受机械取栓以及接受静脉溶栓联合机械取栓的不同程度血栓通透性(TP)患者的长期功能结局。
我们对2016年1月至2020年10月期间因大血管闭塞导致急性缺血性卒中而单纯接受机械取栓或桥接治疗的连续患者进行了回顾性分析。通过将入院时计算机断层扫描血管造影上的血栓衰减增加(TAI)与非增强计算机断层扫描进行比较来量化TP。将TAI分为高通透性或低通透性后,进行Fisher精确检验以评估不同治疗方法与良好功能结局[90天改良Rankin量表评分(90天mRS)为0至2]之间的关联。
我们的研究共纳入73例患者。35例(47.9%)血栓被分类为高通透性血栓,TAI≥24 HU,另外38例为低通透性血栓。32例患者观察到90天mRS为0至2的良好结局。在低通透性血栓患者中,桥接治疗组的良好结局比单纯取栓组更常见(p = 0.013),而在高通透性血栓患者中,两种治疗组的长期神经学结局无显著差异(p = 0.094)。
建议低通透性血栓患者先接受静脉注射阿替普酶,然后进行血管内取栓,而高通透性血栓患者可单纯进行取栓。